Closed
You're reading the free version. Trader adds the live tape and alerts. Start tracking

Price with disclosed trades

Daily closes, past year · marks sit on transaction dates, sized by value

4 trades

Disclosure transactions for Karyopharm Therapeutics Inc
Reporting person Filed Transaction Transaction value Source Actions
Abate Kristin Chief Accounting Officer Oct 19, 2026 3-day lag Sale Oct 16, 2026 $1.65K Filed shares x price SEC Form 4 View filing
Abate Kristin Chief Accounting Officer Oct 2, 2026 1-day lag Sale Oct 1, 2026 $449.82 Filed shares x price SEC Form 4 View filing
Abate Kristin Chief Accounting Officer Sep 2, 2026 1-day lag Sale Sep 1, 2026 $38.38 Filed shares x price SEC Form 4 View filing
Poulton Stuart EVP, Chief Development Officer Jul 30, 2026 2-day lag Sale Jul 28, 2026 $1.34K Filed shares x price SEC Form 4 View filing
Abate Kristin Chief Accounting Officer
Sale
Calculated transaction value
$1.65K 4,788 shares @ $0.34
Traded
Oct 16, 2026
Filed
Oct 19, 2026
Abate Kristin Chief Accounting Officer
Sale
Calculated transaction value
$449.82 378 shares @ $1.19
Traded
Oct 1, 2026
Filed
Oct 2, 2026
Abate Kristin Chief Accounting Officer
Sale
Calculated transaction value
$38.38 19 shares @ $2.02
Traded
Sep 1, 2026
Filed
Sep 2, 2026
Poulton Stuart EVP, Chief Development Officer
Sale
Calculated transaction value
$1.34K 189 shares @ $7.1
Traded
Jul 28, 2026
Filed
Jul 30, 2026